Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma

Br J Ophthalmol. 2015 Oct;99(10):1320-2. doi: 10.1136/bjophthalmol-2015-306633. Epub 2015 Apr 29.

Abstract

Topotecan fluoresces when exposed to ultraviolet (UV) light. Our observations with UV light in retinoblastoma cases has allowed us to minimise and manage inadvertent skin contact, guide periocular injections and leakage from such injections and document conjunctival contact after periocular injection in addition to demonstrating the drug in the vitreous after intravitreal injection. The technique is safe, inexpensive and easy to perform.

Keywords: Drugs; Imaging; Pharmacology; Treatment other; Vitreous.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Fluorescein Angiography / methods*
  • Fundus Oculi
  • Humans
  • Intravitreal Injections
  • Retinal Neoplasms / diagnosis
  • Retinal Neoplasms / drug therapy*
  • Retinoblastoma / diagnosis
  • Retinoblastoma / drug therapy*
  • Topoisomerase I Inhibitors / administration & dosage
  • Topotecan / administration & dosage*
  • Vitreous Body / pathology*

Substances

  • Topoisomerase I Inhibitors
  • Topotecan